Amgen Inc.

Dow's nearly 100-point rally led by gains for shares of Amgen, IBM

2:01 p.m. Sept. 20, 2023

- MarketWatch Automation

IBM, Amgen share gains contribute to Dow's nearly 200-point jump

11:13 a.m. Sept. 20, 2023

- MarketWatch Automation

Dow's 320-point rally led by gains in shares of JPMorgan Chase, Amgen

12:16 p.m. Sept. 14, 2023

- MarketWatch Automation

Dow's nearly 100-point drop led by losses for shares of Amgen, Procter & Gamble

10:09 a.m. Sept. 12, 2023

- MarketWatch Automation

These four Dow stocks take top prizes for dividend growth

8:13 a.m. Sept. 9, 2023

- Philip van Doorn

As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs 

12:38 p.m. Sept. 2, 2023

- Eleanor Laise

Amgen, FTC Settle Over $27.8 Billion Horizon Deal

2:54 p.m. Sept. 1, 2023

- Karishma Vanjani

FTC settles with Amgen over $27.8 billion takeover of Horizon Therapeutics

10:01 a.m. Sept. 1, 2023

- Chris Matthews

FTC settles with Amgen over $27.8 billion takeover of Horizon Therapeutics

9:20 a.m. Sept. 1, 2023

- Chris Matthews

These Stocks Led the Market in August. It's Still Tech's Year.

5:26 p.m. Aug. 31, 2023

- Angela Palumbo

Medicare's Plan to Negotiate Drug Discounts Won't Hit Pharma Hard, Analysts say

3:56 p.m. Aug. 30, 2023

- Bill Alpert

First 10 Drugs Picked for Medicare Price Negotiations

3:26 p.m. Aug. 29, 2023

- Bill Alpert

Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations

3:22 p.m. Aug. 29, 2023

- Eleanor Laise

After calling the S&P 500’s climb this year, this strategist says hang on, the gains aren’t over.

9:33 a.m. Aug. 29, 2023

- Barbara Kollmeyer

Merck, Amgen, AbbVie products among first 10 drugs selected for Medicare price negotiations

7:50 a.m. Aug. 29, 2023

- Eleanor Laise

3M, Jabil, Hawaiian Electric, Boston Scientific, XPeng, Nvidia, and More Stock Market Movers

4:14 p.m. Aug. 28, 2023

- Joe Woelfel

Horizon Therapeutics shares climb after FTC pauses challenge of deal with Amgen

8:03 a.m. Aug. 28, 2023

- Eleanor Laise

Biden Administration to Reveal 10 Drugs for Which Medicare Will Pay Less

3:00 a.m. Aug. 28, 2023

- Josh Nathan-Kazis

As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit — even if their drugs aren’t on the list 

1:07 p.m. Aug. 26, 2023

- Eleanor Laise

Stock buybacks spur wealth inequality and stifle innovation. Should they be banned?

9:44 a.m. Aug. 26, 2023

- Ciara Linnane

A New Way to Protect Against Heart Attacks

2:32 p.m. Today2:32 p.m. Sept. 23, 2023

- The Wall Street Journal Interactive Edition

Big Pharma’s Battle With the Biden Administration Could Have Legs

9:46 a.m. Sept. 13, 2023

- The Wall Street Journal Interactive Edition

Biden FTC’s Antitrust Bark Proves Worse Than Its Bite

2:33 a.m. Sept. 7, 2023

- The Wall Street Journal Interactive Edition

Amgen’s Deal for Horizon Therapeutics Clears Key Hurdle

2:32 a.m. Sept. 2, 2023

- The Wall Street Journal Interactive Edition

Drug Price Controls Mean Slower Cures

4:44 p.m. Aug. 30, 2023

- The Wall Street Journal Interactive Edition

Expensive Drugs Targeted for First U.S. Price Negotiations

4:40 p.m. Aug. 31, 2023

- The Wall Street Journal Interactive Edition

FTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics

6:03 p.m. Aug. 28, 2023

- The Wall Street Journal Interactive Edition

Biotech M&A Rebound Bodes Well for Venture Investors

2:33 a.m. Aug. 11, 2023

- The Wall Street Journal Interactive Edition

Apple, Amazon, Starbucks to Report in Packed Earnings Week

1:43 p.m. Aug. 1, 2023

- The Wall Street Journal Interactive Edition

How AbbVie’s Humira Still Reigns, Despite New Competition

9:55 a.m. Aug. 1, 2023

- The Wall Street Journal Interactive Edition

A Soap Maker Cracks the Code to ‘Made in America’

2:34 a.m. July 26, 2023

- The Wall Street Journal Interactive Edition

Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion

4:15 p.m. July 14, 2023

- The Wall Street Journal Interactive Edition

Lina Khan Is Taking on the World’s Biggest Tech Companies—and Losing

7:00 a.m. July 13, 2023

- The Wall Street Journal Interactive Edition

The Drugs That Are Gaining on Ozempic

6:30 p.m. July 3, 2023

- The Wall Street Journal Interactive Edition

Even Mark Cuban Can’t Fix This Broken Drug System

2:32 a.m. June 6, 2023

- The Wall Street Journal Interactive Edition

Elizabeth Warren and the FTC Are the Least of Amgen’s Problems

2:32 a.m. May 25, 2023

- The Wall Street Journal Interactive Edition

Walmart, Tesla, Micron: Stocks That Defined the Week

2:32 a.m. May 20, 2023

- The Wall Street Journal Interactive Edition

Antitrust Gone Wild Against Amgen

9:42 a.m. May 19, 2023

- The Wall Street Journal Interactive Edition

Sanofi Wins Supreme Court Patent Dispute With Amgen

2:33 a.m. May 19, 2023

- The Wall Street Journal Interactive Edition

FTC Moves to Block Amgen’s $27.8 Billion Deal for Horizon Therapeutics

3:34 p.m. June 2, 2023

- The Wall Street Journal Interactive Edition